Clinical Trial Update: 3MDR to Treat PTSD With mTBI (3MDR) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 3MDR therapy for comorbid posttraumatic stress disorder and traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder
• Traumatic Brain Injury

Drugs mentioned

• 3MDR therapy (multimodal motion-assisted memory desensitization and reconsolidation)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Posttraumatic Stress Disorder, Traumatic Brain Injury | Phase 2 | Status: COMPLETED